Why Is Protagonist Therapeutics, Inc. (NASDAQ: PTGX) Stock Up Today?

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) Summary

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is trading up +2.83% at $136.03, reflecting a positive shift in investor sentiment today. The stock opened at $137.49 and has moved between $135.39 and $138.08 so far.

Trading volume is 244218, which is 65% below its average, and the price action suggests buying interest.

Technically, PTGX on the NASDAQ is trading above its 50-day moving average of $119.55 and above its 200-day moving average of $97.31, indicating short-term and long-term strength.

Analyst sentiment is bullish. Meyka's AI assigns PTGX a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +2.20% in 1 month ($139.02), -4.18% in 1 year ($130.34), and +131.31% in 5 years ($314.64).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.